Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001096906-14-001629

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 14, 2014 14.12M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 $303.14K
Stockholders Equity Q3 2014 · Dec 31, 2013 $819.77K
Current Liabilities Q3 2014 · Sep 30, 2014 $874.63K
Current Liabilities Q3 2014 · Dec 31, 2013 $421.63K
Current Assets Q3 2014 · Sep 30, 2014 $1.18M
Current Assets Q3 2014 · Dec 31, 2013 $1.24M
Total Assets Q3 2014 · Sep 30, 2014 $1.18M
Total Assets Q3 2014 · Dec 31, 2013 $1.24M
Operating Cash Flow Q3 2014 · Sep 30, 2013 −$1.37M
Sga Expense Q3 2014 · Sep 30, 2013 $9.61K
Sga Expense Q3 2014 · Sep 30, 2013 $23.43K
Rd Expense Q3 2014 · Sep 30, 2013 $312.67K
Rd Expense Q3 2014 · Sep 30, 2013 $618.74K
Net Income Q3 2014 · Sep 30, 2013 −$489.31K
Net Income Q3 2014 · Sep 30, 2013 −$1.67M
Operating Income Q3 2014 · Sep 30, 2013 −$489.61K
Operating Income Q3 2014 · Sep 30, 2013 −$1.67M